✦ LIBER ✦

Pretreatment serum HCV RNA levels with a branched DNA assay predict the efficacy of interferon treatment in genotype 1B patients with chronic hepatitis C, but not in 2A and 2B

✍ Scribed by Oshita, M.; Hayashi, N.; Kasahara, A.; Hagiwara, H.; Hijioka, T.; Katayama, K.; Fusamoto, H.; Kamada, T.

Book ID: 122446900
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 167 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)28857-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-276 Serum HCV-RNA level and the mutati

P-276 Serum HCV-RNA level and the mutation in the interferon sensitivity determining region of chronic hepatitis C patients with genotype 1B infection

✍ T Murakami; N Enomoto; I Sakuma; N Izumi; F Marumo; C Sato 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Efficacy of pegylated interferon α-2a an

Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis

✍ Nicola Coppola, Mariantonietta Pisaturo, Gilda Tonziello… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 275 KB

Usefulness of simple assays for serum co

Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy

✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4

Predictive value of the IL28B polymorphi

Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b

✍ Tomokazu Kawaoka; C. Nelson Hayes; Waka Ohishi; Hidenori Ochi; Toshiro Maekawa; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Efficacy of 24 weeks treatment with pegi

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

✍ Stefan Zeuzem; Maria Buti; Peter Ferenci; Jan Sperl; Yves Horsmans; Janusz Cianc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A Randomized Study of Extended Treatment

A Randomized Study of Extended Treatment With Peginterferon α-2b Plus Ribavirin Based on Time to HCV RNA Negative–Status in Patients With Genotype 1b Chronic Hepatitis C

✍ Ide, Tatsuya; Hino, Teruko; Ogata, Kei; Miyajima, Ichiro; Kuwahara, Reiichiro; K 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB